SCHEMBL2436085

SCHEMBL2436085

COC(=O)C1CCC(OC(F)(C(=O)Cc2ccc(Nc3nc4ccccc4o3)c(Cl)c2)N2CCCC2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 11/20 0.53
ITGB1 P05556 8/20 0.53
RORC P51449 1/20 0.39
SSTR5 P35346 2/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
MAPT P10636 3/20 0.37
USP2 O75604 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
OPRK1 P41145 1/20 0.37
HRH1 P35367 1/20 0.37
HTR2B P41595 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
PKM P14618 1/20 0.37
TSHR P16473 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2436082 1.00 ITGA4 (0.53) ITGA4ITGB1RORCSSTR5NPC1
SCHEMBL2432616 0.93 ITGB1 (0.62) ITGA4ITGB1RORCSSTR5NPC1
SCHEMBL2432614 0.93 ITGB1 (0.62) ITGA4ITGB1RORCSSTR5NPC1
SCHEMBL2436146 0.92 ITGA4 (0.45) ITGA4ITGB1RORCSSTR5MAPT
SCHEMBL2436149 0.92 ITGA4 (0.45) ITGA4ITGB1RORCSSTR5MAPT
SCHEMBL2432661 0.92 ITGA4 (0.45) ITGA4ITGB1RORCSSTR5NPC1
SCHEMBL2432722 0.92 ITGB1 (0.54) ITGA4ITGB1NPC1RAB9AOPRK1
SCHEMBL2436763 0.90 ITGB1 (0.54) ITGA4ITGB1OPRK1
SCHEMBL2432515 0.90 ITGA4 (0.56) ITGA4ITGB1RORCOPRK1POLB
SCHEMBL2433176 0.89 ITGB1 (0.43) ITGA4ITGB1RORCSSTR5NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1346982-B1 VLA-4 INHIBITORS DAIICHI SEIYAKU CO (JP) 2011-09-14 EP disclosed
US-7157487-B2 Vla-4 inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-01-02 US disclosed
US-20040110945-A1 Vla-4 inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-06-10 US disclosed
EP-1346982-A1 VLA-4 INHIBITORS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-09-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110945-A1 Vla-4 inhibitors VCAM1, ITGA1, ITGB4 ITGA4 4/4885ITGB1 5/4885RORC 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.